Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFRSF10A Antikörper (N-Term)

TNFRSF10A Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN3042972
  • Target Alle TNFRSF10A Antikörper anzeigen
    TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))
    Bindungsspezifität
    • 13
    • 7
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 110-125, N-Term
    Reaktivität
    • 88
    • 5
    • 3
    • 1
    • 1
    Human
    Wirt
    • 47
    • 41
    Kaninchen
    Klonalität
    • 49
    • 39
    Polyklonal
    Konjugat
    • 48
    • 8
    • 6
    • 6
    • 5
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFRSF10A Antikörper ist unkonjugiert
    Applikation
    • 44
    • 32
    • 25
    • 19
    • 17
    • 11
    • 6
    • 5
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Verwendungszweck
    Rabbit IgG polyclonal antibody for Tumor necrosis factor receptor superfamily member 10A(TNFRSF10A) detection. Tested with WB in Human.
    Sequenz
    TIKLHDQSIG TQQWEH
    Kreuzreaktivität (Details)
    No cross reactivity with other proteins.
    Produktmerkmale
    Rabbit IgG polyclonal antibody for Tumor necrosis factor receptor superfamily member 10A(TNFRSF10A) detection. Tested with WB in Human.
    Gene Name: tumor necrosis factor receptor superfamily, member 10a
    Protein Name: Tumor necrosis factor receptor superfamily member 10A
    Aufreinigung
    Immunogen affinity purified.
    Immunogen
    A synthetic peptide corresponding to a sequence at the N-terminus of human DR4(110-125aa TIKLHDQSIGTQQWEH).
    Isotyp
    IgG
    Top Product
    Discover our top product TNFRSF10A Primärantikörper
  • Applikationshinweise
    WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human, The detection limit for TNFRSF10A is approximately 1 ng/lane under reducing conditions.
    Notes: Tested Species: Species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities.
    Other applications have not been tested. Optimal dilutions should be determined by end users.
    Kommentare

    Antibody can be supported by chemiluminescence kit ABIN921124 in WB.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
    Konzentration
    500 μg/mL
    Buffer
    Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
    Konservierungsmittel
    Thimerosal (Merthiolate), Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    At -20°C for one year. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
    Haltbarkeit
    12 months
  • Liu, Zuo, Wang, Chen, Yang, Wang, Zhu: "miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT." in: Oncotarget, Vol. 5, Issue 13, pp. 4959-71, (2014) (PubMed).

    Fu, Ren, Wang, Fei, Wang, Wang: "DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD." in: Oncogene, Vol. 31, Issue 10, pp. 1311-22, (2012) (PubMed).

    Zhang, Niu, Yang, Lu, Chen: "The occurrence and regional distribution of DR4 on herniated disc cells: a potential apoptosis pathway in lumbar intervertebral disc." in: Spine, Vol. 33, Issue 4, pp. 422-7, (2008) (PubMed).

  • Target
    TNFRSF10A (Tumor Necrosis Factor Receptor Superfamily, Member 10a (TNFRSF10A))
    Andere Bezeichnung
    TNFRSF10A (TNFRSF10A Produkte)
    Synonyme
    APO2 antikoerper, CD261 antikoerper, DR4 antikoerper, TRAILR-1 antikoerper, TRAILR1 antikoerper, TNFRSF10A antikoerper, TNF receptor superfamily member 10a antikoerper, tumor necrosis factor receptor superfamily member 26 antikoerper, tumor necrosis factor receptor superfamily, member 10a antikoerper, TNFRSF10A antikoerper, LOC510798 antikoerper
    Hintergrund
    TNFRSF10A(Tumor Necrosis Factor Receptor Subfamily Member 10A), also known as APO2, DR4 or TRAILR1, is a protein that in humans is encoded by the TNFRSF10A gene. The protein encoded by this gene is a member of the TNF-receptor superfamily. By analysis of radiation hybrids, Marsters et al.(1997) mapped the DR4 gene to 8p21. The TRAIL receptor DR5, and 2 decoy receptors for TRAIL, DCR1, and DCR2, are located in the same region, suggesting that these receptors arose from recent gene duplication events. Pan et al.(1997) found that, as with FAS, TNFR1, and DR3, overexpression of DR4 induced apoptosis. However, unlike the other 3 death receptors, DR4 did not use FADD to transmit the death signal, suggesting the use of distinct proximal signaling machinery.

    Synonyms: Apo 2 antibody|Apo2 antibody|CD 261 antibody|CD261 antibody|CD261 antigen antibody|Cytotoxic ligand TRAIL receptor antibody|Cytotoxic TRAIL receptor antibody|Death receptor 4 antibody|DR 4 antibody|DR4 antibody|MGC9365 antibody|NF related apoptosis-inducing ligand receptor 1 antibody|T10A antibody|TNF related apoptosis inducing ligand receptor 1 antibody|TNF-related apoptosis-inducing ligand receptor 1 antibody|TNFRSF10A antibody|TR10A_HUMAN antibody|TRAIL R1 antibody|TRAIL receptor 1 antibody|TRAIL-R1 antibody|TRAILR 1 antibody|TRAILR1 antibody|Tumor necrosis factor receptor superfamily member 10a antibody|Tumor necrosis factor receptor superfamily member 10A precursor antibody
    UniProt
    O00220
    Pathways
    Apoptose, Positive Regulation of Endopeptidase Activity
Sie sind hier:
Kundenservice